Aptose Biosciences Inc. (NASDAQ:) inventory has plunged to a 52-week low, touching down at $0.4, as the corporate faces a difficult interval marked by a steep decline in its market valuation. Over the previous yr, Aptose Biosciences has seen its inventory value erode dramatically, with a 1-year change displaying a precipitous drop of -89.9%. This […]